Synaptogenix IncNASDAQ:SNPX
- LAST PRICE1.0500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.0400/ 61
- Ask / Lots1.1100/ 1
- Open / Previous Close1.0900 / 1.0500
- Day Range
- 52 Week Range
- Volume136,325
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SNPX |
|---|---|---|
| 09:32 ET | 484 | 1.09 |
| 09:35 ET | 500 | 1.07 |
| 09:37 ET | 5500 | 1.03 |
| 09:39 ET | 9828 | 1.05 |
| 09:42 ET | 13818 | 1.074 |
| 09:44 ET | 100 | 1.08 |
| 09:46 ET | 350 | 1.05 |
| 09:50 ET | 1000 | 1.0718 |
| 09:51 ET | 100 | 1.08 |
| 09:53 ET | 10700 | 1.08 |
| 09:55 ET | 9900 | 1.09 |
| 09:57 ET | 5675 | 1.1399 |
| 10:00 ET | 1000 | 1.09 |
| 10:08 ET | 315 | 1.12 |
| 10:09 ET | 1408 | 1.111 |
| 10:11 ET | 200 | 1.11 |
| 10:15 ET | 1400 | 1.1 |
| 10:22 ET | 210 | 1.1 |
| 10:24 ET | 100 | 1.1 |
| 10:33 ET | 100 | 1.1 |
| 10:38 ET | 100 | 1.095 |
| 10:40 ET | 22846 | 1.095 |
| 10:44 ET | 2577 | 1.09 |
| 10:45 ET | 200 | 1.09 |
| 10:49 ET | 100 | 1.09 |
| 10:51 ET | 200 | 1.09 |
| 10:54 ET | 100 | 1.1 |
| 11:02 ET | 100 | 1.08 |
| 11:05 ET | 200 | 1.1 |
| 11:09 ET | 300 | 1.0812 |
| 11:16 ET | 750 | 1.08 |
| 11:18 ET | 328 | 1.08 |
| 11:32 ET | 300 | 1.08 |
| 11:52 ET | 4600 | 1.06 |
| 11:54 ET | 2300 | 1.05 |
| 11:56 ET | 24797 | 1.05 |
| 12:08 ET | 100 | 1.07 |
| 12:21 ET | 4000 | 1.08 |
| 12:42 ET | 1000 | 1.065 |
| 12:53 ET | 2000 | 1.065 |
| 01:15 ET | 100 | 1.08 |
| 01:31 ET | 3000 | 1.0584 |
| 01:38 ET | 100 | 1.06 |
| 01:49 ET | 1000 | 1.0681 |
| 02:34 ET | 100 | 1.07 |
| 03:19 ET | 900 | 1.07 |
| 03:50 ET | 100 | 1.05 |
| 03:57 ET | 100 | 1.05 |
| 04:00 ET | 100 | 1.05 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Synaptogenix Inc | 7.6M | -0.5x | --- |
Avenue Therapeutics Inc | 7.5M | -0.4x | --- |
Quoin Pharmaceuticals Ltd | 7.3M | 0.0x | --- |
Burzynski Research Institute Inc | 8.0M | -12.1x | --- |
Mosaic Immunoengineering Inc | 7.2M | -2.7x | --- |
X T L Biopharmaceuticals Ltd | 7.1M | -2.4x | --- |
Company Information
Synaptogenix, Inc., formerly Neurotrope BioScience, Inc. is a biopharmaceutical company. The Company is principally focused on developing therapeutics for patients with neurodegenerative diseases and developmental disorders. The Company is developing a product platform based upon a drug candidate called Bryostatin-1, which is synthesized from a natural product (bryostatin) that is isolated from a marine invertebrate organism, for the treatment of Alzheimer’s disease (AD). Its lead product candidate is bryostatin-1. Bryostatin-1 is a Protein Kinase C Epsilon (PKC e), a and e activator that was originally developed as a potential anticancer drug. The Company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
Contact Information
- Headquarters
- 1185 AVENUE OF THE AMERICAS, 3RD FLOORNEW YORK, NY, United States 10036
- Phone
- 973-242-0005
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Joshua Silverman
- President, Chief Scientific Officer, Director
- Daniel Alkon
- Chief Executive Officer, Director
- Alan Tuchman
- Independent Vice Chairman of the Board
- William Singer
- Chief Financial Officer, Executive Vice President, Treasurer, Secretary
- Robert Weinstein
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 7.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.07 |
Book Value | $4.98 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
